CD4 and neoplasm: Furthermore, the proportion of CD4+CD25+FoxP3+ Tregs in tumors decreased by approximately 10% in the poly IC + IF4G3986–994 group, indicating a reduction in the immunosuppressive tumor microenvironment alongside robust immune activation (Figure 7m,n).